ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,449,000 | -28.3% | 35,850 | +2.1% | 0.61% | -7.9% |
| Q2 2015 | $2,020,000 | -70.2% | 35,100 | -67.0% | 0.66% | -73.3% |
| Q1 2015 | $6,769,000 | +247.0% | 106,320 | +236.5% | 2.46% | +235.1% |
| Q4 2014 | $1,951,000 | +313.3% | 31,600 | +130.7% | 0.74% | +383.6% |
| Q2 2014 | $472,000 | – | 13,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |